Public Health & Policy >
Product Alert
FDA Approves First Antidepressant Transdermal Patch
ROCKVILLE, Md. - The FDA has approved a once-a-day antidepressant patch that delivers a monoamine oxidase inhibitor. Called Emsam (selegiline), the patch can be used at its lowest dose without the dietary restrictions that accompany oral MAO inhibitors.
Mar 01, 2006
FDA Says It Plans Label Changes for Concerta and Ritalin
WASHINGTON-The FDA said it plans to strengthen the warning label for Concerta, the popular long-acting version of Ritalin (methylpenidate) in response to post-marketing surveillance reports of psychiatric and cardiovascular adverse effects.
Jun 29, 2005
FDA Okays Single Dose Antibiotic for Pneumonia and Sinusitis
NEW YORK-The FDA has approved Zmax (azithromycin extended release) as a single-dose treatment for adults with pneumonia and certain types of acute mild-to-moderate bacterial sinusitis and pneumonia, Pfizer announced yesterday.
Jun 14, 2005
FDA Warns of Excess Mortality to Elderly With Antipsychotics
WASHINGTON-The FDA has issued a public health advisory on the entire class of atypical antipsychotic drugs, pointing to an apparent excess of mortality for older patients with dementia, particularly when the agents are used off-label to treat behavioral disorders.
Apr 12, 2005